$252 Million is the total value of Kopp Family Office, LLC's 14 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 7.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NEO | Sell | NeoGenomics Inc. | $86,138,000 | -5.8% | 1,785,605 | -11.8% | 34.19% | -9.6% |
| HZNP | Sell | Horizon Therapeutics Public Limited Company | $59,250,000 | +15.7% | 540,895 | -1.1% | 23.52% | +11.0% |
| VCEL | Buy | Vericel Corporation | $26,829,000 | -5.3% | 549,775 | +1.9% | 10.65% | -9.2% |
| IEFA | Sell | ISHARES TRcore msci eafe | $25,143,000 | -1.3% | 338,628 | -0.4% | 9.98% | -5.3% |
| JAMF | Buy | JAMF HOLDING CORP | $21,299,000 | +116.2% | 552,910 | +88.4% | 8.45% | +107.4% |
| IEMG | Sell | ISHARES TRcore msci emkt | $16,506,000 | -9.3% | 267,266 | -1.7% | 6.55% | -13.1% |
| FIVN | Buy | Five9, Inc. | $14,624,000 | -12.9% | 91,547 | +0.0% | 5.80% | -16.5% |
| MITK | New | MITEK SYS INC | $1,774,000 | – | 95,898 | +100.0% | 0.70% | – |
| IVV | ISHARES TRcore s&p500 etf | $126,000 | 0.0% | 292 | 0.0% | 0.05% | -3.8% | |
| ISTB | ISHARES TRcore 1 5 yr usd | $105,000 | 0.0% | 2,050 | 0.0% | 0.04% | -2.3% | |
| IAGG | ISHARES TRcore intl aggr | $43,000 | 0.0% | 783 | 0.0% | 0.02% | -5.6% | |
| IMTB | ISHARES TRcr 5 10 yr etf | $39,000 | 0.0% | 764 | 0.0% | 0.02% | -6.2% | |
| IJH | ISHARES TRcore s&p mcp etf | $39,000 | -2.5% | 147 | 0.0% | 0.02% | -11.8% | |
| IJR | ISHARES TRcore s&p scp etf | $23,000 | 0.0% | 207 | 0.0% | 0.01% | -10.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NeoGenomics Inc. | 16 | Q3 2023 | 90.1% |
| Vericel Corporation | 16 | Q3 2023 | 14.5% |
| Five9, Inc. | 16 | Q3 2023 | 11.2% |
| ISHARES TR | 13 | Q3 2023 | 16.7% |
| ISHARES TR | 13 | Q3 2023 | 10.6% |
| ISHARES TR | 13 | Q3 2023 | 0.1% |
| ISHARES TR | 13 | Q3 2023 | 0.1% |
| ISHARES TR | 13 | Q3 2023 | 0.0% |
| ISHARES TR | 13 | Q3 2023 | 0.0% |
| ISHARES TR | 13 | Q3 2023 | 0.0% |
View Kopp Family Office, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| RTI Surgical Holdings, Inc. | July 07, 2020 | ? | ? |
| NEOGENOMICS INC | January 07, 2020 | 4,844,625 | 4.6% |
| OCLARO, INC. | January 04, 2019 | ? | ? |
| SUPERCONDUCTOR TECHNOLOGIES INC | October 05, 2018 | ? | ? |
View Kopp Family Office, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-16 |
View Kopp Family Office, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.